Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6375)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2013 (publication date) through Jul 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiao X, Lu HJ, Zhai MM, Tan ZJ, Zhi HN, Liu XM, Liu CH, Zhang DP. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer. World J Gastroenterol 2013; 19(48): 9425-9431 [PMID: 24409072 DOI: 10.3748/wjg.v19.i48.9425] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9425.htm |
| Number | Citing Articles |
| 1 |
Andreas Scorilas, Konstantinos Mavridis. Predictions for the future of kallikrein-related peptidases in molecular diagnostics. Expert Review of Molecular Diagnostics 2014; 14(6): 713 doi: 10.1586/14737159.2014.928207
|
| 2 |
Kun Wu, Boyu Wu, Kangpeng Yan, Qunhua Ding, Zhiguo Miao. KLK10 promotes the progression of KRAS mutant colorectal cancer via PAR1‐PDK1‐AKT signaling pathway. Cell Biology International 2024; 48(4): 440 doi: 10.1002/cbin.12113
|
| 3 |
Ai Li, Yan Li, Yueyue Li, Mingming Zhang, Hong Zhang, Feixue Chen. Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer. PeerJ 2023; 11: e16243 doi: 10.7717/peerj.16243
|
| 4 |
Takaya Shimura, Masahide Ebi, Tomonori Yamada, Tamaki Yamada, Takahito Katano, Yu Nojiri, Hiroyasu Iwasaki, Satoshi Nomura, Noriyuki Hayashi, Yoshinori Mori, Hiromi Kataoka, Marsha A. Moses, Takashi Joh. Urinary kallikrein 10 predicts the incurability of gastric cancer. Oncotarget 2017; 8(17): 29247 doi: 10.18632/oncotarget.16453
|
| 5 |
Mekdes Debela, Viktor Magdolen, Wolfram Bode, Hans Brandstetter, Peter Goettig. Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10. Biological Chemistry 2016; 397(12): 1251 doi: 10.1515/hsz-2016-0205
|
| 6 |
Xiaocong Geng, Yueyang Liu, Sandra Diersch, Matthias Kotzsch, Sabine Grill, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Julia Dorn, Henning Ulrich. Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer. PLOS ONE 2017; 12(11): e0186847 doi: 10.1371/journal.pone.0186847
|
| 7 |
Kazuya Kato, Takehiro Noda, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hidenori Takahashi, Mamoru Uemura, Tadafumi Asaoka, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation. Cancer Science 2024; 115(5): 1520 doi: 10.1111/cas.16144
|
| 8 |
Shwan Majid Ahmad, Basima Sadq Ahmed, Karzan Ghafur Khidhir, Heshu Sulaiman Rahman. Prospective quantitative gene expression analysis of kallikrein-related peptidase KLK10 as a diagnostic biomarker for childhood acute lymphoblastic leukemia. PeerJ 2022; 10: e13489 doi: 10.7717/peerj.13489
|
| 9 |
LEI LI, NAN XU, NING FAN, QINGCHUN MENG, WENCHAO LUO, LIJIA LV, WEI MA, XIAOYU LIU, LU LIU, FEI XU, HUAXIN WANG, WEIFENG MAO, YAN LI. Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro. Oncology Reports 2015; 34(5): 2325 doi: 10.3892/or.2015.4211
|
| 10 |
Ana Carolina B. Stefanini, Bianca Rodrigues da Cunha, Tiago Henrique, Eloiza H. Tajara. Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/946572
|
| 11 |
Mustafa A. El Sherbini, Amal A. Mansour, Maha M. Sallam, Emtiaz A. Shaban, Zeinab A. Shehab ElDin, Amr H. El-Shalakany. KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study. Journal of Ovarian Research 2018; 11(1) doi: 10.1186/s13048-018-0407-y
|
| 12 |
T. Kryza, M.L. Silva, D. Loessner, N. Heuzé-Vourc'h, J.A. Clements. The kallikrein-related peptidase family: Dysregulation and functions during cancer progression. Biochimie 2016; 122: 283 doi: 10.1016/j.biochi.2015.09.002
|
| 13 |
Daria Salyakina, Nicholas F Tsinoremas. Non-coding RNAs profiling in head and neck cancers. npj Genomic Medicine 2016; 1(1) doi: 10.1038/npjgenmed.2015.4
|
| 14 |
Yuwen Jiao, Haojun Yang, Jun Qian, Yu Gong, Hanyang Liu, Siyuan Wu, Liang Cao, Liming Tang. miR‑3664‑5P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF‑κB signaling pathway through targeting MTDH. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4680
|
| 15 |
Xiaoping Liu, Xiao Chang, Rui Liu, Xiangtian Yu, Luonan Chen, Kazuyuki Aihara, Jason A Papin. Quantifying critical states of complex diseases using single-sample dynamic network biomarkers. PLOS Computational Biology 2017; 13(7): e1005633 doi: 10.1371/journal.pcbi.1005633
|
| 16 |
Panagiotis G. Adamopoulos, Panagiotis Tsiakanikas, Andreas Scorilas. Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies. Biological Chemistry 2018; 399(8): 821 doi: 10.1515/hsz-2017-0342
|